LOADING
Comparing Merck & Company (MRK) and Coinbase Global (COIN) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | COIN |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $283.1B | $52.3B |
| P/E Ratio | 15.7 | 44.5 |
| Forward P/E | 22.4 | 56.2 |
| PEG Ratio | 3.50 | 0.76 |
| EPS | $7.28 | $4.45 |
| Revenue Growth (YoY) | 5.0% | -22.2% |
| Profit Margin | 28.1% | 18.3% |
| Return on Equity | 36.9% | 10.1% |
| Dividend Yield | 2.87% | -- |
| Beta | 0.28 | 3.61 |
| 52-Week High | $124.22 | $444.64 |
| 52-Week Low | $70.74 | $139.36 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.